A Stand Up To Cancer grant to spark new collaborative research in pancreatic cancer. Funded by the Nina Nicolai SU2C Pancreatic Cancer Fund, this award incentivizes investigators to form novel partnerships (especially across existing SU2C teams) to explore high-risk, high-reward ideas for treating pancreatic cancer. The goal is to accelerate development of new therapies through synergistic team science.
Eligibility Criteria:
- Teams must include two or more investigators from different institutions or SU2C research “Dream Teams” to foster fresh collaboration . At least one investigator should have a strong track record in pancreatic cancer research.
- Open to senior and junior scientists; SU2C encourages involvement of early-career researchers in a mentored team environment .
- Proposals should clearly outline the innovative idea and how the collaboration will enhance it (e.g. combining unique expertise or data from each team member). Focus must be on pancreatic cancer (e.g. novel targets, drug combinations, biomarkers, or immunotherapy approaches).
- No citizenship restrictions. Investigators at academic, nonprofit, or industry labs may apply, provided they can demonstrate effective collaboration.
Funding Details:
- Award Amount: $200,000 total for the collaborative project (a one-year term) . Funds are typically shared among team members’ institutions as per project needs.
- Use of Funds: Supports research supplies, assays, limited equipment, and salaries/stipends necessary for the project.
- Emphasis on quick execution – SU2C expects funded projects to yield initial results within 12–18 months.
- No Overhead: SU2C awards generally do not allow indirect costs, focusing all funds on research activities.
Deadline:
- Application Deadline: January 6, 2026 . Apply via ProposalCentral (search “Stand Up To Cancer”) .
- Award notifications by Spring 2026. Projects are expected to start promptly, by mid-2026, given the urgency in pancreatic cancer.
Where to go for further information: